ArticleFrontiers in oncology2026

Multi-omics and experimental validation reveal ISG20L2 as a potential pro-oncogenic regulator in gastric cancer.

Song Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.